Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
October 3, 2023 Off

Qkine Appoints Industry-leading CliniSciences as New European Distributor for Their Growth Factor and Cytokine Portfolio

By BusinessWire

CAMBRIDGE, England–(BUSINESS WIRE)–#Cambridge—Qkine, a leading manufacturer of high purity bioactive proteins, is pleased to announce its sales distribution agreement with…

EUCAIM kicks off first platform to fuel collaborative innovation and data sharing across Europe
October 3, 2023 0

EUCAIM kicks off first platform to fuel collaborative innovation and data sharing across Europe

By Dino Mustafić

The EUCAIM consortium and the European Commission have the first public release of its platform, Cancer Image Europe, marking a major milestone in the project’s development and an exciting step towards achieving its vision and goals.

October 3, 2023 Off

Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac Regeneration

By GlobeNewswire

Novel AAV-Based Approach Regenerated Myocardial Cells and Demonstrated Durable Benefit to Heart Function in Rodent Model of Chronic Cardiac Ischemic…

October 3, 2023 Off

TFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines

By GlobeNewswire

FORT WORTH, Texas, Oct. 02, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing…

October 3, 2023 Off

Immunovant Announces Closing of Upsized Common Stock Financing and Full Exercise of Underwriters’ Option to Purchase Additional Shares

By GlobeNewswire

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal…

October 3, 2023 Off

New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prostate Cancer and Low-Very Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO

By BusinessWire

− Post-hoc analysis from Blue Earth Diagnostics’ Phase 3 SPOTLIGHT trial provides data about treatment planning, particularly when curative salvage…

October 3, 2023 Off

Athersys Director Jane Wasman Appointed Board Chair

By BusinessWire

CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces changes to its…

October 3, 2023 Off

Takeda Provides Update on EXKIVITY® (mobocertinib)

By BusinessWire

OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) today announced that, following discussions with the U.S. Food and Drug Administration (FDA),…

October 3, 2023 Off

Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release

By BusinessWire

CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it plans to release its results for the…

October 3, 2023 Off

Aura Biosciences Strengthens and Expands Leadership Team with Key Appointments

By BusinessWire

J. Jill Hopkins, M.D., Appointed as Chief Medical Officer and President of Research & Development Mark Plavsic, Ph.D., Appointed as…

Posts navigation

Previous 1 2 3 4 … 5,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Beaconcure Technologies Welcomes Additions to Leadership Team

October 3, 2023 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off
Proudly powered by WordPress | Theme: Envo Magazine